Zydus Lifesciences got the US health regulator's nod to market its hypertension drug Bisoprolol Fumarate and Hydrochlorothiazide tablets in the American market, said the Indian pharmaceutical ...

Glenmark Pharmaceuticals Ltd on January 27 said its U.S. subsidiary has received final approval from the country's health regulator for its generic Bisoprolol Fumarate and Hydrochlorothiazide ...

Serious adverse events occurred in 14.5 and 14.3% of 255 and 251 patients in the bisoprolol and placebo groups, respectively (relative risk, 1.01; 95% confidence interval, 0.62 to 1.66; P = 0.96).

New Delhi: Zydus Lifesciences on Tuesday said it has received final approval from the US health regulator to market its generic version of bisoprolol fumarate tablets used to treat high blood ...

Glenmark Pharmaceuticals, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP ...